Patent · 2023 · pending
Treatment of CPN1 Related Diseases and Disorders
siRNA and antisense oligonucleotides targeting CPN1, for conditions associated with CPN1 mutations.
- Filings
- 1
- Status
- Pending
- First priority
- Dec 22, 2023
Patent · 2023 · pending
siRNA and antisense oligonucleotides targeting CPN1, for conditions associated with CPN1 mutations.